Peptron
1 known investors
Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.
Investors · 1
Frequently asked questions
- What does Peptron do?
- Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.
- Who are Peptron's investors?
- Peptron's investors include Aju IB Invesment Corporation.